Relationship between HPV16/18 E6 and p53, p21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: Comparative study by using tissue microarray technology

Experimental Oncology

Volumn 28, Issue 3, 2006, Pages 235-240

  Qi, Z L ^a   Huo, X ^a   Xu, X J ^a   Zhang, B ^a   Du, M G ^b   Yang, H W ^a   Zheng, L K ^a   Li, J ^b   Shen, Z Y ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b Shaanxi Chaoying Biotechical Company   (China)

Author keywords

Esophageal cell carcinoma; Human papillomavirus; Immunohistochemistry; Tissue microarray

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; KI 67 ANTIGEN; PROTEIN E6; PROTEIN MDM2; PROTEIN P53;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PROTO-ONCOGENE PROTEINS C-MDM2; REPRESSOR PROTEINS; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33750948214     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Gamliel Z. Incidence, epidemiology, and etiology of esophageal cancer. Chest Surg Clin N Am 2000; 10: 441-50.
2. Matsha T, Erasmus R, Kafuko AB, Mugwanya D, Stepien A and Parker MI. Human papillomavirus associated with oesophageal cancer. J Clin Pathol 2002; 55: 587-90.
3. Syrjanen KJ. Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch Geschwulstforsch 1982; 52: 283-92.
4. Syrjanen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002; 55: 721-8.
5. Tripodi S, Chang F, Syrjänen S, Shen Q, Cintorino M, Alia L, Santopietro R, Tosi P, Syrjanen K. Quantitative image analysis of esophageal squamous cell carcinoma from the high-incidence area of China, with special reference to tumour progression and papillomavirus (HPV) involvement. Anticancer Res 2000; 20: 3855-62.
6. Farnadi M, Tahmasebi Z, Merat S, Kamangar F, Nasrollahzadeh D, Malekzadeh R. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol 2005; 11: 1200-3.
7. Shen ZY, Hu SP, Lu LC, Tang CZ, Kuang ZS, Zhong SP, Zeng Y. Detection of human papillomavirus in esophageal carcinoma. J Med Virol 2002; 68: 412-6.
8. Shen ZY, Cen S, Xu LY, Cai WJ, Chen MH, Shen J, Zeng Y. E6/E7 genes of human papilloma virus type 18 induced immortalization of human fetal esophageal epithelium. Oncol Rep 2003; 10: 1431-6.
9. Hamilton SR, Aaltonen LA. WHO classification tumor of the digestive system. In: Tumours of the Oesophagus. Cabbert HE, Shimoda T, Haimaut P, Nakamura Y, Field JK, Inoue H, eds. France: IARC Press Lyon, 2000; 9-36.
10. Kato H, Yoshikawa M, Fukai Y, Tajima K, Masuda N, Tsukada K, Kuwano H, Nakajima T. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers. Anticancer Res 2000; 20: 345-9.
11. Xue Q, Sano T, Kashiwabara K, Oyama T, Nakajima T. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of Lung. Jpn J Cancer Res 2001; 92: 1-8.
12. Ohbu M, Kobayashi N, Okayasu I. Expression of cell cycle regulatory proteins in the multistep process of oesophageal carcinogenesis: stepwise over-expression of cyclin E and p53, reduction of p21(WAF1/CIP1) and dysregulation of cyclin D1 and p27(KIP1). Histopathology 2001; 39: 589-96.
13. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-9.
14. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992; 69: 1237-45.
15. Wu X, Bayle JH, Olson D, Levine AJ. The p53-mdm-2 autoregulatory feedback loop. Genes Dev 1993; 7: 1126-32.
16. Chen J, Wu X, Lin J, Levine AJ. Mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol 1996; 16: 2445-52.
17. Watanabe M, Kuwano H, Tanaka S, Toh Y, Masuda H, Sugimachi K. A significant morphological transformation is recognized in human esophageal cancer cells with an amplification overexpression of the cyclin D1 gene. Int J Oncol 1999; 15: 1103-8.
18. Shamma A, Doki Y, Shiozaki H, Tsujinaka T, Inoue M, Yano M, Kimura Y, Yamamoto M, Monden M. Cyclin D1 overexpression in esophageal dysplasia: a possible biomarker for carcinogenesis of esophageal squamous cell carcinoma. Int J Oncol 2000; 16: 261-6.
19. Lavergne D, de Villiers EM. Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer 1999; 80: 681-4.
20. Matsha T, Erasmus R, Kafuko AB, Mugwanya D, Stepien A, Parker MI. Human papillomavirus associated with oesophageal cancer. J Clin Pathol 2002; 55: 587-90.
21. Munger K. The role of human papillomaviruses in human cancers. Front Biosci 2002; 7: d641-9.
22. Yang G, Zhang Z, Liao J, Seril D, Wang L, Goldstein S, Yang CS. Immunohistochemical studies on Waf1, p21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in northern China. Int J Cancer 1997; 4: 746-51.
23. Bahnassy AA, Zekri AR, Abdallah S, El-Shehaby AM, Sherif GM. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival. Pathol Int 2005; 55: 53-62.
24. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinase. Nature 1993; 366: 701-4.
25. Waf1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma. Clin Cancer Res 1999; 5: 2445-9.
26. Chen J, Wu X, Lin J, Levine AJ. Mdm2 inhibits the G1 arrest and apoptisis functions of the p53 tumor suppressor protein. Mol Cell Biol 1996; 16: 2445-52.
27. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-25.
28. Wang LD, Shi ST, Zhou Q, Goldstein S, Hong JY, Shao P, Qiu SL, Yang CS. Changes in p53 and cyclin D1 protein level and cell proliferation in different stages of Henan esophageal and gastric-cardia carcinogenesis. Int J Cancer 1994; 59: 514-9.
29. Wang LD, Hong JY, Qiu SL, Gao HG, Yang CS. Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res 1993; 53: 1783-7.
30. Kawakubo H, Ozawa S, Ando N, Kitagawa Y, Mukai M, Ueda M, Kitajima M. Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma. Oncol Rep 2005; 14: 1453-9.
31. Buchynska LG, Nesina IP. Expression of the cell cycle regulators p53, p21(WAF1/CIP1) and p16(INK4a) in human endometrial adenocarcinoma. Exp Oncol 2006; 28: 152-5.
32. Lin YC, Wu MY, Li DR, Wu XY, Zheng RM. Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma. World J Gastroenterol 2004; 10: 3235-9.
33. Nakagawa H, Zukerberg L, Togawa K, Meltzer SJ, Nishihara T, Rustgi AK. Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer 1995; 76: 541-9.
34. Zhao M, Kim YT, Yoon BS, Kim SW, Kang MH, Kim SH, Kim JH, Kim JW, Park YW. Expression profiling of cyclin B1 and D1 in cervical carcinoma. Exp Oncol 2006; 28: 44-8.
35. Olvera M, Wickramasinghe K, Brynes R, Bu X, Ma Y, Chandrasoma P. Ki67 expression in different epithelial types in columnar lined oesophagus indicates varying levels of expanded and aberrant proliferative patterns. Histopathology 2005; 47: 132-40.